Download by
Scanning QR Code
No Stock Yet
No Data
Dacheng Biotechnology: inside information (1) profit warning; and (2) partial resumption of operation of the Group's production facilities in Shanghai
Hong Kong stocks change, Agricultural stocks strengthen India temporarily bans wheat exports G7 early warning on food security
On May 16, Gelonghui, Chinese starch rose 10.45%, and Dacheng biochemical technology soared nearly 32%. India's General Administration of Foreign Trade issued a notice on the 13th, imposing a temporary ban on Indian wheat exports, effective immediately. The announcement pointed out that the rise in international food prices has threatened the food security of India and its neighboring countries. Agriculture ministers of the Group of Seven (G-7) held a meeting in Stuttgart, Germany from the 13th to 14th to discuss the global food security caused by the conflict between Russia and Ukraine. The meeting said that the conflict between Russia and Ukraine may have serious consequences for world food security, and restrictions on Ukraine's food exports have further exacerbated global food tensions.
Dacheng Biotechnology: annual report 2021
Dacheng Biotechnology: (1) further announcement of audited annual results in 2021; and (2) change of the date of the annual general meeting and suspension of share transfer registration
Dacheng Biotechnology (00809) further delays the publication of audited annual results in 2021
Zhitong Financial APP News, Dacheng biochemical Technology (00809) announced that the company is expected to issue an announcement containing the 2021 audited annual results on or before April 30, 2022. However, in response to the COVID-19 outbreak, a number of cities in China, including Changchun, where the Group's main operation is located, have been cordoned off. it is expected that the audit process (mainly the issuance and receipt of audit confirmation letters to the group's banks, creditors or debtors (the "audit confirmation letter procedure") will not be completed on schedule. The company expects that the process of reviewing the confirmation letter will be completed shortly after the blockade in China is lifted. And
Dacheng Biotechnology: (1) notice of board meeting; (2) further delay in the publication of audited annual results in 2021; and (3) delay in sending the 2021 annual report.
Dacheng biochemical Technology (00809.HK) 2021 revenue of HK $747 million decreased by 12.1% compared with the same period last year.
Dacheng biochemical Technology (00809.HK) announced that for the year ended December 31, 2021, the company realized an income of HK $747 million, a decrease of 12.1% over the same period last year. The owner of the company had a loss of HK $400m and a basic loss of HK4.5 cents per share. During the year, due to the continuing impact of COVID-19 's outbreak and the tight operating cash flow caused by the long-term challenging operating environment, the Group continued to suspend operation of most of its production facilities. The suspension of operations and the consumption of most of the inventory in the previous year led to a decline in sales.
Dacheng Biotechnology (00809) reported a loss of HK $401 million attributable to shareholders in 2021, which was 83.5% lower than the same period last year.
Zhitong Financial APP News, Dacheng Biotechnology (00809) released unaudited results for the year ended December 31, 2021, with income of HK $747 million, down 12.1% from the same period last year; loss attributable to the company's owners was HK $401 million, down 83.5% from the same period last year; and basic loss per share was HK4.5 cents per share. During the year, due to the continuing impact of COVID-19 's outbreak and the tight operating cash flow caused by the long-term challenging operating environment, the Group continued to suspend operation of most of its production facilities. The suspension of operations and the consumption of most of the inventory in the previous year led to a decline in sales.
Dacheng Biotechnology: unaudited annual results announcement for the year ended December 31, 2021
Dacheng Biotechnology (00809) delays the publication of audited annual results in 2021
Zhitong Financial APP News, Dacheng biochemical Technology (00809) issued an announcement that due to the recent outbreak of COVID-19 in mainland China and Hong Kong, China, resulting in the flow of people, logistics and other restrictions, the Group's ability to collect and provide some necessary audit information on time was restricted, resulting in delays in the review process of the Group's annual results for the year ended December 31, 2021. The group's audit process was not completed on schedule. Due to the suspension of the Group's express delivery services in some major operating cities in mainland China and Hong Kong, China, and the need for employees of the Group's major operating facilities in Changchun, Harbin, Jinzhou and Shanghai to inspect
Loading...
No Stock Yet